However, drugs in the treatment of medications that are known as SGLT2 inhibitors do not show any significant gains in preventing cardiac or stroke attacks even in patients with cardiovascular disease.
Diabetes can cause heart problems, which are heart medications that benefit from significant attention from doctors and patients.
Brigant, Boston Women's Hospital, Stephen Widow, Senior Investigator, found that the discovery of these SIGLT2 drugs is important for the use of SGLT2 drugs.
AstraZeneca hopes that new data will help increase the number of patients in the broad range of fluxia.
The clinical study was released in a report published Saturday at the American Heart Association Annual Conference published in the New York Journal of Medicine. It was first conducted by 17,000 patients. .
These results show that the risk of entry into the hospital following a heart attack is 27% causing kidney disease.
Two small studies involving SGLT2 drugs have focused on diagnostic diseases, but the overall picture of the study has shown that it is important to prevent the cardiac arrest.
"When analyzing these three studies, the main benefit of these classical medicines is to reduce cardiovascular risk," said Vivit.
For decades, diabetes specialists focus on lowering glucose levels in the bloodstream. But a five-year survival rate is only 50% of risk for cardiovascular malformation, predicting diabetes with other problems, and a more comprehensive approach.
"It's important that we expect a ratio of glucose to reduce the cost of life expectancy, and not only effective drugs to reduce blood glucose," said the doctor.
Jardine, who produces Eli Lilli and Boehurger Ingehym, and has already been competing with Inconsistan Johnson and Johnson, has already shown the long-term vision for a diagnostic cardiovascular disease.
A wide market opens with the diagnosis of the digestive tract, as well as the primary resistance.
In ferksigue-related treatments, infections, hysteria, nausea and gangrene cancers were not understood in the Declarreal analyzes. Sometimes it is common in diseases such as SGLT, but there is an increase in genital disease.